Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sionna Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Sionna Therapeutics

Sionna Therapeutics

Series B

Sionna Therapeutics: Innovating small molecule therapies for cystic fibrosis treatment.

HQ
Natick, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize cystic fibrosis (CF) treatment, Sionna Therapeutics focuses on developing novel small molecule therapies. The company aims to fully normalize CFTR function, specifically targeting the most common genetic mutation affecting CF patients, ΔF508. As a clinical-stage company, Sionna Therapeutics is dedicated to advancing its pipeline through various stages of drug development, from discovery and lead optimization to DC/IND-enabling and clinical phases.

Sionna Therapeutics has garnered attention for its innovative approach and commitment to excellence in patient care. The company is supported by a team of experts in the field of cystic fibrosis and has attracted significant investment from leading healthcare investors. Its groundbreaking work has the potential to significantly impact the lives of CF patients by addressing the underlying genetic causes of the disease, aiming for a future where CFTR function is fully normalized.

Sionna Therapeutics - Similar Companies

Synspira logo

Synspira

Santi Therapeutics logo

Santi Therapeutics

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Nested Therapeutics logo

Nested Therapeutics

nestedtx.com

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

vrtx.com

cystetic Medicines logo

cystetic Medicines

SphynKx Therapeutics logo

SphynKx Therapeutics

Spinogenix logo

Spinogenix

spinogenix.com

Citrine Medicine logo

Citrine Medicine

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Rectify Pharmaceuticals logo

Rectify Pharmaceuticals

rectifypharma.com

Triplet Therapeutics logo

Triplet Therapeutics

triplettx.com

Courage Therapeutics logo

Courage Therapeutics

Cedilla Therapeutics logo

Cedilla Therapeutics

Sionna Therapeutics - Quick Facts

Who are Sionna Therapeutics' competitors?

Companies similar to Sionna Therapeutics include Synspira, Santi Therapeutics, Synnovation Therapeutics and Nested Therapeutics.

When was Sionna Therapeutics founded?

Sionna Therapeutics was founded in 2019.

Where is Sionna Therapeutics' headquarters located?

Sionna Therapeutics' headquarters is located in Natick, MA, US.

When was Sionna Therapeutics' last funding round?

Sionna Therapeutics' most recent funding round was for $110M (USD) in April 2022.

How much has Sionna Therapeutics raised to-date?

As of Apr 19, 2022, Sionna Therapeutics has raised a total of $110M (USD).

How many employees does Sionna Therapeutics have?

Sionna Therapeutics has 33 employees as of Feb 4, 2024.

Sionna Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • secCik: 0002036042
  • ticker: SION
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified